(Q39942709)
Statements
1 reference
Central and peripheral contribution to the antihypertensive action of indoramin (English)
T. Baum
1 May 1975
1 reference
1 reference
32
1 reference
1
1 reference
30-38
1 reference
6
226
A comparison of the cardiovascular actions of indoramin, propranolol, lignocaine, and quinidine (English)
Alps
1972
44
52
Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy-21,901) (English)
Alps
1972
9
503
Inhibition of spontaneous sympathetic nerve activity by the antihypertensive agent Wy-8678 (English)
Baum
1970
12
49
Reduction of sympathetic outflow by central administration of l-dopa, dopamine and norepinephrine (English)
Baum
1973
226
1276
Influence of heart rate on the reduction of sympathetic outflow produced by l-dopa (English)
Baum
1974
Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophane and centrally administered 5-hydroxytryptamine (English)
Baum
1975
31
170
An electronic stimulus artefact suppressor (English)
Freeman
1971
278
231
Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidine (English)
Haeusler
1973
13
380
Pharmacologic studies of indoramin in man (English)
Royds
1972
2
340
Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures (English)
Schmitt
0 references
17
293
New evidence for an α-adrenergic component in the sympathetic centres: centrally mediated decrease in sympathetic tone by l-dopa and its antagonism by piperoxane and yohimbine (English)
Schmitt
1972
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference